Clinical Trial Update: Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tri Association in patients with advanced epithelial ovarian cancer in relapse (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Epithelial Ovarian Cancer, Relapse | Phase 2 | Status: UNKNOWN